Application of unified protocol as a transdiagnostic treatment for emotional disorders during COVID-19: An internet-delivered randomized controlled trial

Table 3 Demographic characteristics of the sample, n = 102

Item characteristic	Baseline value	Control group value	UP group value	Test	P value
Categorical variables
Sex, n (%)
Women	48 (47.1)	21	27	χ² = 0.35	0.55
Man	54 (52.9)	30	24
Principal diagnosis, n (%)
Depressive disorder	45 (44.1)	22	23	χ² = 1.41	0.23
Anxiety disorder	57 (55.9)	26	31
Marital status, n (%)
Single	34 (33.3)	20	14	χ² = 11.33	0.001
In relationship	68 (66.7)	35	33
Psychological disorders, n (%)
MDD	40 (48.6)	18	22
Dysthymia	5 (7.1)	4	1
GAD	34 (31.4)	15	19
SAD	23 (12.9)	11	12
Continues variables (mean ± SD)
Age, yr	28.07 ± 5.07	27.92 ± 4.67	28.18 ± 5.49	t(100) = 0.28	0.77
Anxiety	11.14 ± 1.88	11.35 ± 2.05	10.88 ± 1.69	t(100) = 1.26	0.21
Depression	10.97 ± 3.75	11.24 ± 1.75	10.71 ± 1.70	t(100) = 1.09	0.26
Emotion dysregulation	49.69 ± 7.82	49.08 ± 7.10	50.18 ± 8.04	t(100) = 0.80	0.4
Positive affect	26.49 ± 3.80	26.88 ± 3.92	26.10 ± 3.66	t(100) = 1.05	0.29
Negative affect	27.44 ± 3.42	26.59 ± 3.66	27.74 ± 3.01	t(100) = 1.48	0.14
Healthy emotionality	59.84 ± 8.82	60.33 ± 9.46	58.90 ± 11.35	t(100) = 1.67	0.09

GAD: Generalized anxiety disorder; MDD: Major depressive disorder; SAD: Social anxiety disorder; SD: Standard deviation; t: Independent t-test; UP: Unified protocol.